Appraisal of guidelines and variations in recommendations on drug therapy for invasive aspergillosis prevention and treatment
The development processes and reporting of invasive aspergillosis -related clinical practice guidelines varied and their quality requires improvement. The guideline recommendations have changed since the approval of isavuconazole.
Authors
- Sun Ju (ORCID: https://orcid.org/0000-0001-8321-3586)
- Dawei Yang (ORCID: https://orcid.org/0000-0002-8928-143X)
- Haishan Wang (ORCID: https://orcid.org/0000-0002-7959-7377)
- Wei Meng (ORCID: https://orcid.org/0000-0001-5451-3125)
- Hongyan Li (ORCID: https://orcid.org/0000-0002-1158-5871)
- Jing Wang (ORCID: https://orcid.org/0000-0002-4351-3039)
Institutions
- Qingdao University (CN)
- Yantai University (CN)
- Yuhuangding Hospital (CN)
- Affiliated Hospital of Qingdao University (CN)
- Yantaishan Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-03-31
- DOI
- https://doi.org/10.3389/fphar.2025.1443487
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40